Abstract
Isolation of tick-borne relapsing fever (TBRF) spirochetes has proven to be a useful tool to understand their distribution by geographic areas where the tick vectors inhabit. However, their isolation and culture are not easy and in general an animal model is needed to achieve this task. Here, argasid ticks were collected from a neighborhood in Ciudad Caucel, Merida, Mexico, and Borrelia puertoricensis was isolated with an immunosuppressed mouse model. By using this model, a higher number of spirochetes were observed in blood samples, and these were successfully cultivated in Barbour-Stoenner-Kelly (BSK)-IIB media. Genomic analyses confirmed that the isolate to be B. puertoricensis. The present report shows that this spirochete is present in argasid ticks in Ciudad Caucel and presents a potential medical and veterinary health risk.
Author Summary Relapsing fever is a neglected disease caused by spirochetes bacteria of the Borrelia and genus that are different than those in the Lyme disease group. These bacteria are transmitted mostly by Ornithodoros (Alectorobious) soft ticks. In many countries, including Mexico, Ornithodoros species are understudied and often misidentified. In this report we obtained an isolate of Borrelia puertoricensis from ticks captured in a small park in the city of Merida, Yucatan. These results emphasize the need for fine-scale vector surveillance in neighborhoods to determine the abundance of Borrelia species, and to define their impact on humans and domestic and wild animals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee and Institutional Animal Care and Use Committee (CEI-ENCB protocol # ZOO-001-2022e1)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
